课题基金 / 基金详情

mHealth for Patient Self-Management of Opioid Use Disorder - Administrative Supplement

mHealth for Patient Self-Management of Opioid Use Disorder - Administrative Supplement
用于阿片类药物使用障碍患者自我管理的 mHealth - 行政补充
批准号:
10722156
负责人:
Jennifer Sharpe Potter
金额:
$12.13万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-14 至 2024-08-31

项目摘要

项目成果

Jennifer Sharpe Potter的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要
英文摘要
PROJECT SUMMARY / ABSTRACT The opioid crisis is an epidemic with devastating health, social, and economic consequences for the United States. From 1999–2018, almost 450,000 people died from an overdose involving an opioid, including prescription and illicit opioids. Three million US citizens and 16 million individuals worldwide have had or currently suffer from opioid use disorder (OUD). The total economic burden of the opioid crisis in the US is estimated to be more than $200 billion annually. Treatment for OUD involves medication assisted treatment (MAT) combined with counseling or behavioral therapy to manage the illness, achieve and sustain better health, and improve quality of life. Rates of recurrent drug use are high, and access to counseling is limited and costly. While MAT is standard of care and highly effective at reducing acute morbidity and mortality, there are advantages to treatment approaches tailored to address an individual patient’s drug use patterns and drug-related medical, psychiatric, and social problems. While mobile tools exist to support OUD treatment, these products offer only generalized information and not personalized feedback that is responsive to each person’s current status to support their individual recovery. In Phase I, we developed KIOS, an innovative software platform using nonlinear control theory. KIOS tracks multiple interacting symptoms (e.g., craving, mood, pain) to map patient trajectories and deliver timely evidence-based intervention strategies, responding directly to patient-reported needs. Accessible via mobile devices, KIOS provides patients on demand individualized advice and reinforcement of lifestyle interventions to improve self-management during MAT. Phase I beta testing demonstrated significant reductions in key symptoms of OUD and high levels of engagement, usability and patient satisfaction. In Phase II studies, we are evaluating KIOS as a prescription digital health therapeutic suitable for FDA approval concomitant to MAT to treat OUD. The Phase II study contains a 12-week randomized controlled trial designed to satisfy requirements to receive FDA 510(k) clearance. Correspondence with the FDA has led to an expansion of the clinical trial to now include a sham app as a comparator to KIOS. This unexpected addition to the clinical trial has led to the filing of this administrative supplement to develop and test the sham app for use in a randomized controlled trial.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
mHealth for Patient Self-Management of Opioid Use Disorder
  • 批准号:
    10681354
  • 项目类别:
  • 资助金额:
    $68.59万
  • 财政年份:
    2018
  • 负责人:
    Jennifer Sharpe Potter
  • 依托单位:
mHealth for Patient Self-Management of Opioid Use Disorder
  • 批准号:
    10325362
  • 项目类别:
  • 资助金额:
    $86.69万
  • 财政年份:
    2018
  • 负责人:
    Jennifer Sharpe Potter
  • 依托单位:
mHealth for Patient Self-Management of Opioid Use Disorder
  • 批准号:
    10468904
  • 项目类别:
  • 资助金额:
    $94.79万
  • 财政年份:
    2018
  • 负责人:
    Jennifer Sharpe Potter
  • 依托单位:
Treatment of Opioid Dependence and Chronic Pain
海外基金